BE501678A - - Google Patents
Info
- Publication number
- BE501678A BE501678A BE501678DA BE501678A BE 501678 A BE501678 A BE 501678A BE 501678D A BE501678D A BE 501678DA BE 501678 A BE501678 A BE 501678A
- Authority
- BE
- Belgium
- Prior art keywords
- nitrophenyl
- threo
- oxazoline
- acid
- hydroxy
- Prior art date
Links
- 229960005091 Chloramphenicol Drugs 0.000 claims description 10
- WIIZWVCIJKGZOK-RKDXNWHRSA-N Chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003513 alkali Substances 0.000 claims description 5
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 5
- 230000005591 charge neutralization Effects 0.000 claims description 4
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 230000001264 neutralization Effects 0.000 claims description 4
- 238000006386 neutralization reaction Methods 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- -1 hydroxy- (p-nitrophenyl) -methyl group Chemical group 0.000 claims description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000006640 acetylation reaction Methods 0.000 description 3
- 230000000875 corresponding Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001476 alcoholic Effects 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- 150000002918 oxazolines Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- FEWJPZIEWOKRBE-LWMBPPNESA-N (-)-tartaric acid Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 1
- DOOVMQDCXRUFNK-UHFFFAOYSA-N 1-nitrocyclohexa-1,4-diene Chemical compound [O-][N+](=O)C1=CCC=C[CH]1 DOOVMQDCXRUFNK-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- 229960000583 Acetic Acid Drugs 0.000 description 1
- FYAKEEHTJFALDM-UHFFFAOYSA-N C1(C(N1CCOCCN1C(C1=O)=O)=O)=O Chemical compound C1(C(N1CCOCCN1C(C1=O)=O)=O)=O FYAKEEHTJFALDM-UHFFFAOYSA-N 0.000 description 1
- 229960001270 D- TARTARIC ACID Drugs 0.000 description 1
- UUKMSDRCXNLYOO-UHFFFAOYSA-N Lithium borohydride Chemical compound [Li+].[BH4-] UUKMSDRCXNLYOO-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- 210000004940 Nucleus Anatomy 0.000 description 1
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical class C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000004429 atoms Chemical group 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 230000000850 deacetylating Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000003301 hydrolyzing Effects 0.000 description 1
- HPQVWDOOUQVBTO-UHFFFAOYSA-N lithium aluminium hydride Substances [Li+].[Al-] HPQVWDOOUQVBTO-UHFFFAOYSA-N 0.000 description 1
- OCZDCIYGECBNKL-UHFFFAOYSA-N lithium;alumanuide Chemical compound [Li+].[AlH4-] OCZDCIYGECBNKL-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000001546 nitrifying Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atoms Chemical group N* 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE501678A true BE501678A (xx) |
Family
ID=143428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE501678D BE501678A (xx) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE501678A (xx) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2768972A (en) * | 1951-03-13 | 1956-10-30 | Centre Nat Rech Scient | Preparation of n-acyl-beta aryl-serinols |
| US2786870A (en) * | 1954-04-19 | 1957-03-26 | Parke Davis & Co | Synthesis of chloramphenicol and related acylamidodiols |
| US2791595A (en) * | 1953-01-14 | 1957-05-07 | Parke Davis & Co | Long chain esters of nitrophenylaminopropanediols and preparation thereof |
| US2807645A (en) * | 1952-09-24 | 1957-09-24 | Parke Davis & Co | Process for the production of 1-p-nitrophenyl-2-dichloroacetamidopropane-1, 3-diols |
| US2876240A (en) * | 1953-01-14 | 1959-03-03 | Parke Davis & Co | Therapeutically valuable esters and methods for obtaining the same |
-
0
- BE BE501678D patent/BE501678A/fr unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2768972A (en) * | 1951-03-13 | 1956-10-30 | Centre Nat Rech Scient | Preparation of n-acyl-beta aryl-serinols |
| US2807645A (en) * | 1952-09-24 | 1957-09-24 | Parke Davis & Co | Process for the production of 1-p-nitrophenyl-2-dichloroacetamidopropane-1, 3-diols |
| US2791595A (en) * | 1953-01-14 | 1957-05-07 | Parke Davis & Co | Long chain esters of nitrophenylaminopropanediols and preparation thereof |
| US2876240A (en) * | 1953-01-14 | 1959-03-03 | Parke Davis & Co | Therapeutically valuable esters and methods for obtaining the same |
| US2786870A (en) * | 1954-04-19 | 1957-03-26 | Parke Davis & Co | Synthesis of chloramphenicol and related acylamidodiols |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE501678A (xx) | ||
| BE1000039A4 (fr) | Nouvelles 8 alpha-acylamino-ergolines, leur preparation et leur utilisation comme medicaments. | |
| BE897000A (fr) | Nouveaux derives de la 1,4-dihydropyridine,leur preparation et leur utilisation comme medicaments | |
| BE660217A (xx) | ||
| BE506331A (xx) | ||
| EP0837843B1 (fr) | Procede de preparation des formes enantiomeres de l'acide amino alkylaminophenyl propanoique | |
| BE500594A (xx) | ||
| BE776316R (fr) | Nouveaux derives d'acides phenyl-acetiques substitues et procede pour leur | |
| BE503348A (xx) | ||
| BE556188A (xx) | ||
| CH392508A (fr) | Procédé de préparation d'esters de 3-phényl-3-pyrrolidinols | |
| BE752627R (en) | 2-(6-Methoxy-2-naphthyl) propionic acid prepns. - anti-pyretics, analgesics, anti-inflammatory agents | |
| BE516840A (xx) | ||
| BE555876A (xx) | ||
| FR2529553A1 (fr) | Derives d'eburnane, procede pour leur preparation et compositions pharmaceutiques qui les contiennent | |
| BE561038A (xx) | ||
| BE571404A (xx) | ||
| CH330325A (fr) | Procédé de préparation d'une trans-2-phényl-4-carbalcoxy-5-(p-nitro-phényl)-oxazoline | |
| BE502258A (xx) | ||
| BE571842A (xx) | ||
| BE504036A (xx) | ||
| BE887039A (fr) | Nouveaux 2-aminomethyl-6-halogeno-phenols, leur preparation et leur application comme medicaments | |
| BE527112A (xx) | ||
| FR2492374A1 (fr) | Derives du pyrrole protecteurs du myocarde ayant une activite antiarythmique et antiplaquettaire, leur procede de preparation et les medicaments en contenant | |
| BE897034A (fr) | Nouveaux derives du benzene, leur preparation et leur utilisation comme medicaments |